PMDA drug package insert
グロウジェクト皮下注6mg
PMDA Prescription drug · JCRファーマ株式会社 · package insert Jan 29, 2024
Key facts
| Brand names | グロウジェクト皮下注6mg, グロウジェクト皮下注12mg |
|---|---|
| Nonproprietary names | ソマトロピン（遺伝子組換え） |
| Companies | 製造販売元／JCRファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 遺伝子組換え天然型ヒト成長ホルモン製剤 |
| Therapeutic category codes | 872412 |
| YJ codes | 2412402A6024, 2412402A5036 |
| Approval numbers | 22800AMX00463, 22800AMX00464 |
| Package insert edition | 第3版 |
| Package insert date | Jan 29, 2024 |
| PMDA document key | 530210_2412402A5036_1 |
| PMDA company code | 530210 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: